Immunogenicity of Protein Therapeutics 2012
May 3 - 4, 2012
Boston MA , Stati Uniti
Immunogenicity continues to be a major concern for the biologics industry regarding its impact on safety and efficacy. This event examines factors that contribute to immunogenicity, development of predictive tools, and approaches to overcome this problem. It also presents expert advice on pre-clinical and clinical assessment strategies, risk assessment and regulatory considerations and guidance.
Eventi correlati
Immunogenicity of Protein Therapeutics April 29 - 30, 2013
Immunogenicity of Protein Therapeutics May 3 - 4, 2012
Immunogenicity of Protein Therapeutics May 12 - 13, 2011